GB202111001D0 - Organic compound and their uses - Google Patents

Organic compound and their uses

Info

Publication number
GB202111001D0
GB202111001D0 GBGB2111001.0A GB202111001A GB202111001D0 GB 202111001 D0 GB202111001 D0 GB 202111001D0 GB 202111001 A GB202111001 A GB 202111001A GB 202111001 D0 GB202111001 D0 GB 202111001D0
Authority
GB
United Kingdom
Prior art keywords
organic compound
organic
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2111001.0A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BenevolentAI Cambridge Ltd
Original Assignee
BenevolentAI Cambridge Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BenevolentAI Cambridge Ltd filed Critical BenevolentAI Cambridge Ltd
Priority to GBGB2111001.0A priority Critical patent/GB202111001D0/en
Publication of GB202111001D0 publication Critical patent/GB202111001D0/en
Priority to JP2024505332A priority patent/JP2024528072A/ja
Priority to PCT/GB2022/052010 priority patent/WO2023007185A1/en
Priority to EP22754497.0A priority patent/EP4377313A1/en
Priority to US18/293,645 priority patent/US20240343729A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB2111001.0A 2021-07-30 2021-07-30 Organic compound and their uses Ceased GB202111001D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB2111001.0A GB202111001D0 (en) 2021-07-30 2021-07-30 Organic compound and their uses
JP2024505332A JP2024528072A (ja) 2021-07-30 2022-07-29 イミダゾール有機化合物及び炎症性腸疾患に対するその使用
PCT/GB2022/052010 WO2023007185A1 (en) 2021-07-30 2022-07-29 Imidazole organic compounds and their use against inflammatory bowel disease
EP22754497.0A EP4377313A1 (en) 2021-07-30 2022-07-29 Imidazole organic compounds and their use against inflammatory bowel disease
US18/293,645 US20240343729A1 (en) 2021-07-30 2022-07-29 Imidazole organic compounds and their use against inflammatory bowel disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2111001.0A GB202111001D0 (en) 2021-07-30 2021-07-30 Organic compound and their uses

Publications (1)

Publication Number Publication Date
GB202111001D0 true GB202111001D0 (en) 2021-09-15

Family

ID=77651254

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2111001.0A Ceased GB202111001D0 (en) 2021-07-30 2021-07-30 Organic compound and their uses

Country Status (5)

Country Link
US (1) US20240343729A1 (https=)
EP (1) EP4377313A1 (https=)
JP (1) JP2024528072A (https=)
GB (1) GB202111001D0 (https=)
WO (1) WO2023007185A1 (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013005798A1 (ja) * 2011-07-06 2013-01-10 持田製薬株式会社 新規含窒素複素環誘導体
WO2013050527A1 (en) * 2011-10-05 2013-04-11 H. Lundbeck A/S Quinazoline derivatives as pde10a enzyme inhibitors

Also Published As

Publication number Publication date
WO2023007185A1 (en) 2023-02-02
US20240343729A1 (en) 2024-10-17
JP2024528072A (ja) 2024-07-26
EP4377313A1 (en) 2024-06-05

Similar Documents

Publication Publication Date Title
PL3792259T3 (pl) Związek heterocykliczny oraz organiczne urządzenie elektroluminescencyjne zawierające ten związek
IL304222A (en) Alternative pyridotriazine compounds and their uses
SG11202003974XA (en) Macrocyclic compound serving as weel inhibitor and applications thereof
KR102709732B9 (ko) 모노아민 화합물 및 이를 포함하는 유기 전계 발광 소자
IL316531A (en) Compounds and their uses
IL283961A (en) organic compound
CA196643S (en) Bolt
EP4212526A4 (en) HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE THEREOF
EP4230629A4 (en) NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE THEREOF
GB202012170D0 (en) Organic compounds
EP4050001A4 (en) HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING SAME
CA196645S (en) Bolt
EP3345891A4 (en) Amine compound and organic light-emitting device comprising same
GB202004094D0 (en) New compounds and uses
KR102249719B9 (ko) 유기 화합물 및 이를 포함하는 유기전계발광소자
IL304819A (en) Tricyclic compounds and their uses
GB202110990D0 (en) Organic compound and their uses
GB202114238D0 (en) Organic compounds
KR102250355B9 (ko) 유기 화합물 및 이를 포함하는 유기전계발광소자
EP4095216A4 (en) ORGANIC ELECTROLUMINESCENT ELEMENT
CA196644S (en) Bolt
GB202111001D0 (en) Organic compound and their uses
IL311521A (en) Compounds targeting EGFRVIII and their uses
EP3709375A4 (en) CONNECTION WITH AN INDIAN CARBAZOLE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENT ELEMENT
GB202401911D0 (en) Novel organic fungicide

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)